TR199800253A2 - Sülfonamid ikame etmis kromanlar. - Google Patents

Sülfonamid ikame etmis kromanlar.

Info

Publication number
TR199800253A2
TR199800253A2 TR1998/00253A TR9800253A TR199800253A2 TR 199800253 A2 TR199800253 A2 TR 199800253A2 TR 1998/00253 A TR1998/00253 A TR 1998/00253A TR 9800253 A TR9800253 A TR 9800253A TR 199800253 A2 TR199800253 A2 TR 199800253A2
Authority
TR
Turkey
Prior art keywords
treatment
drug
prevention
obtaining
formula
Prior art date
Application number
TR1998/00253A
Other languages
English (en)
Inventor
Jochen Lang Hans
Brendel Joachim
Gerlach Uwe
Weidmann Klaus
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of TR199800253A2 publication Critical patent/TR199800253A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Abstract

Formül I'in kromanlari (FORMÜL) istem 1'de verilen anlamlari ile R(A), R(B) ve R(1)'den R(8)'e kadar olan degerler siklil adenozinmonofosfat (cAMP) tarafindan açilan K+ kanalinin bloklanmasi için bir ilacin elde edilmesinde; ayrica mide asiti salgilarinin önlenmesi için bir ilacin elde edilmesinde; mide urunun ve bagirsaklarla ilgili alanlarin özellikle de dodenumun tedavi edilmesinde, refluksoesophagitisin tedavi edilmesinde, ishalin tedavi edilmesinde, karincik üstü, ventrikular ve supra ventrikular aritmilerde dahil olmak üzere her tür aritmininin tedavi edilmesinde ve önlenmesinde ve ayni zamanda reentry-aritmilerin kontrollerinde ve hücre titresiminin ardindan meydana gelen kalp ölümlerinin engellenmesinde mükemmel bir sekilde uyum göstermektedirler.
TR1998/00253A 1997-02-20 1998-02-18 Sülfonamid ikame etmis kromanlar. TR199800253A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19706675A DE19706675A1 (de) 1997-02-20 1997-02-20 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
TR199800253A2 true TR199800253A2 (tr) 1998-09-21

Family

ID=7820907

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00253A TR199800253A2 (tr) 1997-02-20 1998-02-18 Sülfonamid ikame etmis kromanlar.

Country Status (21)

Country Link
US (1) US6071953A (tr)
EP (1) EP0860440A1 (tr)
JP (1) JPH10231293A (tr)
KR (1) KR19980071530A (tr)
CN (1) CN1194982A (tr)
AR (1) AR011153A1 (tr)
AU (1) AU5539798A (tr)
BR (1) BR9800708A (tr)
CA (1) CA2229947A1 (tr)
CZ (1) CZ48598A3 (tr)
DE (1) DE19706675A1 (tr)
HR (1) HRP980086A2 (tr)
HU (1) HUP9800374A3 (tr)
IL (1) IL123360A0 (tr)
NO (1) NO980694L (tr)
NZ (1) NZ329788A (tr)
PL (1) PL324942A1 (tr)
SK (1) SK20998A3 (tr)
TR (1) TR199800253A2 (tr)
TW (1) TW474929B (tr)
ZA (1) ZA981376B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895994A3 (de) 1997-08-05 1999-12-15 Hoechst Marion Roussel Deutschland GmbH Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742508A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
JP2002524457A (ja) * 1998-09-04 2002-08-06 ザ プロクター アンド ギャンブル カンパニー 抗不整脈薬として有用な置換ジヒドロベンゾピラン
DE19858253A1 (de) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
WO2000058300A1 (fr) * 1999-03-25 2000-10-05 Nissan Chemical Industries, Ltd. Derives du chroman
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
EP2595623B1 (en) 2010-07-19 2018-02-28 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of delta tocopherol for the treatment of lysosomal storage disorders
WO2014078573A2 (en) 2012-11-16 2014-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988006195A1 (fr) * 1987-02-13 1988-08-25 Centre De Recherches Metallurgiques-Centrum Voor R Installation pour la fabrication en continu d'une feuille metallique extra-mince par depot electrolytique
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
EP0807629B1 (de) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
BR9800708A (pt) 1999-07-20
HUP9800374A2 (en) 2000-07-28
HRP980086A2 (en) 1998-10-31
CA2229947A1 (en) 1998-08-20
NO980694D0 (no) 1998-02-19
AR011153A1 (es) 2000-08-02
NO980694L (no) 1998-08-21
HUP9800374A3 (en) 2001-02-28
CN1194982A (zh) 1998-10-07
DE19706675A1 (de) 1998-08-27
PL324942A1 (en) 1998-08-31
JPH10231293A (ja) 1998-09-02
EP0860440A1 (de) 1998-08-26
KR19980071530A (ko) 1998-10-26
ZA981376B (en) 1998-08-20
AU5539798A (en) 1998-08-27
HU9800374D0 (en) 1998-04-28
IL123360A0 (en) 1998-09-24
SK20998A3 (en) 1998-10-07
US6071953A (en) 2000-06-06
NZ329788A (en) 1999-06-29
TW474929B (en) 2002-02-01
CZ48598A3 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
MY149862A (en) Compounds useful to treat retroviral infections
TR199902203T2 (tr) Fernesil transferaz engelleyici, N-veya C-baglantili imidazoller ile ikame edilmis 1,8-anele kinolinon türevleri.
TR199800253A2 (tr) Sülfonamid ikame etmis kromanlar.
TR200100073T2 (tr) Antiparazitik artemisinin türevleri (endoperoksitler)
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
NO922940L (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
TR199903278T2 (tr) 2-Substitüte 4,5-Diaril imidazoller.
TR199902606T2 (tr) Farnesil transferazi engelleyici kinazolinonlar.
EP1177168A4 (en) CASPASE INHIBITORS AND THEIR USE
AU603525B2 (en) Tetrazole intermediates to antihypertensive compounds
TW289757B (tr)
NO982950L (no) Fenyltiazolderivater med inti-herpesvirus-egenskaper
TR200200749T2 (tr) Kinazolin bileşikleri ve bunları içeren farmasötik bileşikler.
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
ZA9711606B (en) Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
IL148426A0 (en) α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BR0016150A (pt) Compostos, composições e métodos para estìmulo de crescimento e alongamento neuronal
UA66864C2 (uk) Похідні сечовини, фармацевтична композиція і спосіб лікування або профілактики запальних, аутоімунних або респіраторних захворювань
TR200101865T2 (tr) İmidazol bileşimleri ve onların tıbbi kullanımları.
HK1043809A1 (en) Pharmaceutical composition for treating papillomavirus tumours and infection.
BR0100691A (pt) Preparação cosmética ou dermatológica, e, uso da mesma
BR0012032A (pt) Derivado do grupo a de estreptograminas, processo de preparação do mesmo, e composição farmacêutica
TR199801229T2 (tr) ''Metalopeptidaz inhibisyon aktivitesini havi tiol türevleri
NO931527L (no) Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling
CA2168937A1 (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines